Akèy › Kansè Poumon ki pa ti selil › Michigan › Farmington Hills
Etid klinik pou Kansè Poumon ki pa ti selil nan Farmington Hills, MI
13 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Farmington Hills (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Ap rekriteFaz 3
- Corewell Health Farmington Hills Hospital, Farmington Hills
- Henry Ford Health Providence Novi Hospital, Novi · 5 mi lwen
- Henry Ford Medical Center-Columbus, Novi · 5 mi lwen
- ak 2 plis
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Ap rekriteFaz 3
- Henry Ford Health Providence Novi Hospital, Novi · 5 mi lwen
- Henry Ford Health Providence Southfield Hospital, Southfield · 8 mi lwen
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Ap rekriteFaz 1
- ALX Center 8, Farmington Hills
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Ap rekriteFaz 2
- Henry Ford Health Providence Novi Hospital, Novi · 5 mi lwen
- Henry Ford Health Providence Southfield Hospital, Southfield · 8 mi lwen
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Ap rekriteFaz 3
- Research Site, Farmington Hills
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
Ap rekriteFaz 3
- Profound Research, LLC, Farmington Hills
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- Profound Research, LLC, Farmington Hills
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Ap rekriteFaz 3
- Weisberg Cancer Treatment Center, Farmington Hills
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Ap rekriteFaz 1
- Karmanos Cancer Institute, Farmington Hills
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Ap rekriteFaz 2
- Oakland Medical Group, Farmington Hills
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Henry Ford Medical Center-Columbus, Novi · 5 mi lwen
- Henry Ford West Bloomfield Hospital, West Bloomfield · 6 mi lwen
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Henry Ford Medical Center-Columbus, Novi · 5 mi lwen
- Henry Ford West Bloomfield Hospital, West Bloomfield · 6 mi lwen
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
Ap rekriteFaz 1/2
- Research Site, Farmington Hills
Etid Kansè Poumon ki pa ti selil nan lòt vil
- Houston, TX145 etid
- New York City, NY121 etid
- Arlington, VA104 etid
- Nashville, TN97 etid
- Boston, MA90 etid
- Los Angeles, CA87 etid
- St. Louis, MO73 etid
- Chicago, IL61 etid
- Baltimore, MD60 etid
- San Antonio, TX59 etid
- Columbus, OH57 etid
- Washington, DC55 etid
Lòt etid nan Farmington Hills
- Maladi Parkinson13 etid
- Obèsite12 etid
- Sipwa10 etid
- Kansè nan tete10 etid
- Ensifizyans kadyak9 etid
- Kansè poumon8 etid
- Kansè pwostat8 etid
- Maladi Alzheimer8 etid
- Kansè vejik6 etid
- Skleroz Miltip6 etid
- BPCO6 etid
- Fèbli Kognitif Lejè6 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.